Advancements in nanoscience for insulin therapeutics have brought about research for the development of insulin nanocarriers, insulin smart-drug delivery systems (stimuli-responsive), insulin pumps, novel insulin analogs, and insulin nanosensors for the effective treatment of DM. This evidence concerns the gene INS and diabetes mellitus.